My Profile
James Pethokoukis
Where politics and the economy intersect.
See all posts
Tue 1 Dec 2009 | 1:24 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Repligen Corp
Repligen Corp (RGEN.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
RGEN
on other exchanges
As of 30 Nov 2009
4.70
USD
Price Change
+0.05
Percent Change
+1.08%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Total Annual Compensation
Long-Term Incentive Plans
All Other
Fiscal Year Total
As Of 30 Mar 2009
Cooper, Glenn
--
--
--
--
Dawes, Karen
--
--
--
--
Goldberg, Alfred
--
--
--
--
Henry, Earl
--
--
--
--
Herlihy, Walter
365,000
--
247,682
612,682
Kelly, William
190,000
--
106,349
319,663
Rich, Alexander
--
--
--
--
Rusche, James
246,000
--
111,123
357,123
Ryan, Thomas
--
--
--
--
Witt, Daniel
205,000
--
93,363
298,363
Find out more about RGEN.O
Insider Trading